Abstract: The present invention discloses a method for diagnosing the metabolic syndrome by determination of the afamin content in a sample of a body fluid or a tissue sample, wherein the metabolic syndrome is diagnosed if the afamin content in the sample is increased compared to the afamin content in a sample from a person not having the metabolic syndrome.
Type:
Grant
Filed:
September 4, 2008
Date of Patent:
March 20, 2012
Assignee:
Hans Dieplinger
Inventors:
Hans Dieplinger, Florian Kronenberg, Johann Willeit, Stefan Kiechl, Wolfgang Engel